Home World News Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis... World News Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 697 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR How to Spend Time with Friends and Family Now that COVID... August 13, 2020 ESMO Issues First Recommendations on Using Next-Generation Sequencing for Advanced Cancers... August 24, 2020 How Does Ovarian Cancer Form? A New Study Points to MicroRNA July 30, 2020 Breast Cancer Survivor is Swimming the English Channel to Benefit Mental... July 5, 2021 Load more HOT NEWS Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients... New Research Discovers How Scalp Cooling Helps Chemo Patients Keep Their... A Combination of Savolitinib and Osimertinib Prolongs PFS in Patients with... Mom Battling Breast Cancer And Daughter With Alopecia Pose Together To...
